{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:43:46Z","timestamp":1791225826390,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"37-38","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.06.051","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T11:22:42Z","timestamp":1184671362000},"page":"6784-6792","source":"Crossref","is-referenced-by-count":21,"title":["In vitro interactions between macrophages and aluminum-containing adjuvants"],"prefix":"10.1016","volume":"25","author":[{"given":"Anne-C\u00e9cile","family":"Rimaniol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Clayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt. 9","key":"10.1016\/j.vaccine.2007.06.051_bib1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"issue":"February (11)","key":"10.1016\/j.vaccine.2007.06.051_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.vaccine.2004.09.012","article-title":"Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium-containing vaccines in the Cynomolgus monkey","volume":"23","author":"Verdier","year":"2005","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2007.06.051_bib3","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/1521-4141(2001010)31:10<2910::AID-IMMU2910>3.0.CO;2-3","article-title":"Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis","volume":"31","author":"Dupuis","year":"2001","journal-title":"Eur J Immunol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2007.06.051_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol Rev"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2007.06.051_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.20011794","article-title":"Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation","volume":"196","author":"Bellingan","year":"2002","journal-title":"J Exp Med"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2007.06.051_bib6","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.4049\/jimmunol.157.6.2577","article-title":"In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes","volume":"157","author":"Bellingan","year":"1996","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2007.06.051_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2005.08.002","article-title":"(How) do aluminium adjuvants work?","volume":"102","author":"Brewer","year":"2006","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2007.06.051_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.69.2.1151-1159.2001","article-title":"The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism","volume":"69","author":"Ulanova","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.06.051_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-1823-5_8","article-title":"Adjuvant properties of aluminum and calcium compounds","volume":"6","author":"Gupta","year":"1995","journal-title":"Pharm Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.06.051_bib10","first-page":"143","article-title":"Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation","volume":"61","author":"Mannhalter","year":"1985","journal-title":"Clin Exp Immunol"},{"issue":"August (23\u201324)","key":"10.1016\/j.vaccine.2007.06.051_bib11","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.vaccine.2004.01.061","article-title":"Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type","volume":"22","author":"Rimaniol","year":"2004","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2007.06.051_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nmd.2006.02.004","article-title":"Al(OH)3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background","volume":"16","author":"Authier","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2007.06.051_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/cyto.1996.0005","article-title":"Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy","volume":"8","author":"Benveniste","year":"1996","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2007.06.051_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4615-1823-5_7","article-title":"A compendium of vaccine adjuvants and excipients","volume":"6","author":"Vogel","year":"1995","journal-title":"Pharm Biotechnol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2007.06.051_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/14760584.2.2.197","article-title":"MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile","volume":"2","author":"Podda","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2007.06.051_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0264-410X(98)00185-6","article-title":"Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons","volume":"17","author":"Minutello","year":"1999","journal-title":"Vaccine"},{"issue":"July (22)","key":"10.1016\/j.vaccine.2007.06.051_bib17","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0264-410X(99)00088-2","article-title":"A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant","volume":"17","author":"Heineman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.06.051_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","article-title":"MF59. Design and evaluation of a safe and potent adjuvant for human vaccines","volume":"6","author":"Ott","year":"1995","journal-title":"Pharm Biotechnol"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2007.06.051_bib19","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.188.11.2163","article-title":"Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells","volume":"188","author":"Inaba","year":"1998","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.06.051_bib20","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.4049\/jimmunol.166.6.3865","article-title":"CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells","volume":"166","author":"Scholler","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.06.051_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.170.2.735","article-title":"A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily","volume":"149","author":"Zhou","year":"1992","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.06.051_bib22","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1073\/pnas.93.6.2588","article-title":"CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells","volume":"93","author":"Zhou","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2007.06.051_bib23","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1084\/jem.191.9.1581","article-title":"Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA","volume":"191","author":"Kruse","year":"2000","journal-title":"J Exp Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2007.06.051_bib24","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.194.12.1813","article-title":"The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells","volume":"194","author":"Lechmann","year":"2001","journal-title":"J Exp Med"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2007.06.051_bib25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.4049\/jimmunol.168.6.2599","article-title":"Cutting edge: CD83 regulates the development of cellular immunity","volume":"168","author":"Scholler","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.06.051_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.immunol.20.091101.091806","article-title":"The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses","volume":"20","author":"Carreno","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2007.06.051_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2007.06.051_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/85251","article-title":"The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function","volume":"2","author":"Coyle","year":"2001","journal-title":"Nat Immunol"},{"issue":"February (9\u201310)","key":"10.1016\/j.vaccine.2007.06.051_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0264-410X(02)00531-5","article-title":"Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro","volume":"21","author":"Sun","year":"2003","journal-title":"Vaccine"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2007.06.051_bib30","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.173.10.6143","article-title":"Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles","volume":"173","author":"Brewer","year":"2004","journal-title":"J Immunol"},{"issue":"June (5678)","key":"10.1016\/j.vaccine.2007.06.051_bib31","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1089926","article-title":"Promotion of B cell immune responses via an alum-induced myeloid cell population","volume":"304","author":"Jordan","year":"2004","journal-title":"Science"},{"issue":"April (6)","key":"10.1016\/j.vaccine.2007.06.051_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0264-410X(95)00240-2","article-title":"MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice","volume":"14","author":"Higgins","year":"1996","journal-title":"Vaccine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2007.06.051_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/infdis\/174.6.1168","article-title":"MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates","volume":"174","author":"Traquina","year":"1996","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07007384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T15:03:04Z","timestamp":1737298984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07007384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":33,"journal-issue":{"issue":"37-38","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0264410X07007384"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.06.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}